matrihealth

What matrihealth does

matrihealth GmbH is a German biotech company specializing in the extraction, hydrolysis, and processing of high-purity elastin for cosmetics, food, and biomedical research applications. Founded in October 2022 as a spin-off of the Fraunhofer Institute for Microstructure of Materials and Systems (IMWS) in Halle (Saale), the company commercializes over 20 years of Fraunhofer-derived research using its proprietary Peptineer platform technology and patented extraction processes. Core products include matripure for cosmetics, the matriNutra and matriVital food-grade lines (including bovine variants and the matriVital 50 elastin-collagen blend), and R&D products such as ELMA methacrylated elastin for 3D bioprinting, TROPOelastin recombinant human tropoelastin, matripatch and matrisorb wound-care materials, matrispin electrospinning feedstock, matritrace-R labeled elastin, and ELAMIN+ crosslinkable hydrolysate. The company also launched Bounce+ as its first consumer skincare brand to demonstrate matripure in finished formulations.

The business model is B2B ingredient and raw material sales with quote-based pricing, minimum order quantities ranging from 100mg for R&D-grade products to 1kg for food-grade lines, and one-time transactional orders (no recurring subscription or licensing disclosed). Production runs under HACCP and DIN EN ISO 22716 (Cosmetic-GMP) certifications at the Weinbergcampus headquarters. matrihealth combines direct B2B sales to cosmetics manufacturers, food companies, and research institutions with regional distribution partnerships — SLI Chemicals GmbH for food ingredients, Julius Hoesch for cosmetics in German-speaking markets, and Deutsche Lanolin Gesellschaft for cosmetics trade-show presence. Go-to-market relies heavily on industry trade shows (in-cosmetics Global, Vitafoods Europe, SEPAWA Congress, Cosmetic Business) and scientific conferences (DGBM, European Elastin Meeting), supplemented by the company website, e-commerce shop, and LinkedIn presence. Pricing for cosmetics- and food-grade streams is not publicly listed; all engagements are custom-quoted.

Name

matrihealth

Legal name

matrihealth GmbH

Website

https://matrihealth.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

matrihealth GmbH produces high-purity, water-soluble elastin from porcine and bovine sources for cosmetics, food, and biomedical research applications, serving B2B manufacturers in Europe via direct sales and regional distribution partnerships.

Ownership category

akta.pro rank

Product category

Specialty Biopolymers

akta.pro primary industry

Animal-Derived Protein Ingredients (Egg, Collagen/Gelatin, Blood/Plasma Proteins) (AFAJAHAB)

akta.pro secondary industries

Gelatin & Collagen Hydrolysates (Animal-Based Gelling Agents) (AFAJABAD), Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine) (AFAJAKAG), Collagen, Gelatin & Protein Hydrolysates (Animal-Derived) (AFANAGAI), Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids) (CRADAOAJ)

Keywords

• Elastin ingredients
• Biomaterial manufacturing
• Recombinant tropoelastin
• Cosmetic raw materials
• Tissue engineering

Headquarters

HQ city

Haale

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Elastin Raw Material Sales: Direct B2B sales of elastin products including matripure (cosmetics grade), matriNutra and matriVital (food grade), and R&D-grade products. Products sold in various forms (powder, flakes, granules) with minimum order quantities ranging from 100g to 1kg.
2. Biomaterial Product Sales: Sales of specialized elastin-based biomaterials including ELMA, ELMA+, matrispin, matripatch, matrisorb, matritrace-R, and ELAMIN+ for research and medical device applications. Custom product development services for specific customer requirements.
3. Tropoelastin Sales: Recombinant human tropoelastin product (Isoform 2) sold to research institutions and biotech companies for tissue engineering, biomaterial development, and basic research applications.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

matrihealth GmbH manufactures and sells high-purity elastin products derived from porcine and bovine sources for cosmetics, food, medical device, and research end markets. The portfolio includes cosmetic-grade soluble elastin (matripure), food-grade elastin hydrolysates and macromolecular elastin (matriNutra, matriVital, plus bovine variants and matriVital 50), and R&D-grade biomaterials (ELMA methacrylated elastin for 3D bioprinting, recombinant human TROPOelastin, matripatch nanofibers, matrisorb sponges, matrispin electrospinning proteins, matritrace-R labeled elastin, ELAMIN+ amino-enriched elastin), supported by the proprietary Peptineer Platform for chemical modification of elastin-derived peptides.

Product overview

matrihealth GmbH is a biotech company specializing in elastin-based products across multiple market segments. The portfolio includes cosmetic-grade elastin (matripure® line), food-grade elastin products (matriNutra/matriVital lines including bovine variants), and R&D products for tissue engineering and biomaterials (ELMA®, TROPOelastin, matritrace-R, ELAMIN+, matripatch©, matrisorb©, matrispin©). The company operates as a platform of elastin-based offerings spanning from raw materials to semi-finished products for research, cosmetics, food, and medical applications. Recent additions include matriVital 50 combining elastin and collagen, and a new consumer brand Bounce+ for skincare.

Differentiator

Problem solved

Functional benefit

Brands

• matripure®: High-purity soluble elastin hydrolyzate for cosmetic applications.
• matriNutra
• matriVital
• matriVital 50
• matriNutra B
• matriVital B
• ELMA®
• ELMA®+
• matritrace-R
• ELAMIN+
• TROPOelastin
• Bounce+
• matripatch©
• matrisorb©
• matrispin©

Products and services

• matripure® High-purity soluble hydrolyzed elastin for cosmetic applications, optimized for skin care formulations with high water-binding capacity; sold to cosmetics manufacturers with minimum order quantity of 100 g.
• matripure® A Soluble high molecular weight hydrolyzed elastin for technical applications and research; mean molecular weight approximately 32 kDa with elastin peptide content over 90%.
• matripure® B Soluble low molecular weight hydrolyzed elastin for technical applications and research; mean molecular weight approximately 9 kDa with elastin peptide content over 90%.
• matripure® N Macromolecular insoluble natural elastin available as flakes, granulate, or fine powder for technical, scientific, and research applications.
• matriNutra Natural macromolecular elastin for food production and dietary supplements with over 90% protein content and over 30% essential amino acids; minimum order quantity 1 kg, sample size 100 g, delivery 4-6 weeks.
• matriNutra B Bovine-derived macromolecular elastin for texturizing applications in foods and dietary supplements, supporting texture and firmness in solid food applications such as protein bars.
• matriVital High-purity cold water-soluble elastin hydrolysate for food production and dietary supplements; protein content over 90%, cold water soluble up to 100 g/L, delivery 1-2 weeks.
• matriVital B Functional bovine elastin hydrolysate for modern food applications and dietary supplements; high protein content over 90% with a neutral sensory profile.
• matriVital 50 Balanced protein complex of porcine elastin and collagen hydrolysates in a 1:1 ratio for functional foods and dietary supplements.
• ELMA® Methacrylated elastin for 3D bioprinting and tissue engineering; first commercial elastin product enabling bioprinting of artificial elastic tissues.
• ELMA®+ Crosslinkable elastin for bioprinting with solubility up to 30%+ concentrations, enabling precise tuning of polymerized hydrogel properties for advanced tissue engineering.
• TROPOelastin Tag-free recombinant human tropoelastin (Isoform 2, UniProt P15502-2) with mean molecular weight ~60 kDa, comprising all biologically relevant domains; used as a scaffold material for tissue engineering, biomaterial development, and basic research.
• matritrace-R® Rhodamine-labeled elastin (absorption maximum ~566 nm) for tracking in biomaterial systems, release studies, and tissue integration studies; minimum order 100 mg, delivery 6-8 weeks.
• ELAMIN+ Amino-enriched elastin hydrolysate with high density of accessible amino groups for tunable crosslinking and covalent integration into biofunctional systems; available in 1, 2, or 5 gram options with delivery 6-8 weeks.
• matripatch© Electrospun nanofiber nonwoven based on elastin and collagen that mimics the natural extracellular matrix; suitable for cell colonization and tissue engineering applications.
• matrisorb© Highly porous sponge material based on elastin and collagen for medical research and protein-based wound dressings; forms rapidly absorbable hydrogel on contact with liquids; delivery 8-10 weeks.
• matrispin© Tailor-made protein mixture optimized for electrospinning, containing matripure A and matripure B; enables production of nanofibrous webs with up to 90% w/v elastin content combined with gelatin; delivery 6-8 weeks.
• Bounce+ Anti-aging skincare cream representing the first cosmetic application of matrihealth's matripure high-purity elastin, marketed directly to consumers under the Bounce+ brand.

Quantifiable outcome

• Elastin half-life of up to 75 years making it extremely durable in tissue applications
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• SLI Chemicals GmbHcoreChannel Partner/ Reseller/ Distributor · 5 May 2026Distribution partner for dietary supplements and functional ingredients market. First collaboration at Vitafoods Europe 2026 in Barcelona (May 5-7, 2026). SLI Chemicals represents matrihealth in the food ingredients distribution channel.
• Julius Hoesch GmbH & Co KGcoreChannel Partner/ Reseller/ Distributor · 14 April 2026Distribution partner for cosmetics sector in German-speaking markets. Co-exhibited at in-cosmetics Global 2026 in Paris (April 14-16) and SEPAWA Congress 2025 in Berlin (October 15-17). Represents matrihealth at cosmetics trade shows and handles distribution in cosmetics ingredients market.
• Deutsche Lananin Gesellschaft GmbH & Co KGminorChannel Partner/ Reseller/ Distributor · 8 April 2025Partner for presenting at in-cosmetics Global 2025 in Amsterdam (April 8-10). Presented matripure cosmetic applications at their booth (Hall 3, booth 3A91).
• Life Science Cluster Sachsen-AnhaltminorStrategic or Co-development Partner · 2 April 2023Official member of Life-Science-Cluster Saxony-Anhalt network. Cluster serves as networking and interest group for strengthening and connecting companies and research institutions in biotechnology, pharmacy, medicine, and health sectors in Saxony-Anhalt and Central Germany.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Advanced BioMatrix: Advanced BioMatrix supplies collagen, gelatin, elastin and bioink products for 3D bioprinting, tissue engineering and regenerative medicine. Direct competitor to matrihealth's ELMA, matrispin, matripatch and TROPOelastin R&D lines serving biomedical researchers.
• Jellagen Pty Ltd: Jellagen extracts high-purity jellyfish collagen for medical devices, tissue engineering and cell culture applications. An emerging specialty animal-protein competitor in the same biomedical/R&D segment that matrihealth serves with TROPOelastin and ELMA products.
• GELITA AG: GELITA is the world's leading manufacturer of collagen peptides and gelatin for food, cosmetics and pharma - the closest structural analog to matrihealth's animal-derived specialty protein ingredients (matriNutra, matriVital), with overlapping customer bases and regulatory pathways (HACCP/GMP).
• CollPlant Biotechnologies: CollPlant develops recombinant human collagen (rhCollagen) for tissue engineering, 3D bioprinting and medical aesthetics. Direct competitor for biomaterial-grade elastin/collagen proteins (ELMA, matripatch, matrisorb) and shares matrihealth's biomedical R&D customer segment.
• PB Leiner (Tessenderlo Group): PB Leiner produces gelatin, collagen peptides and animal protein hydrolysates for food, nutrition and pharma. Direct overlap with matrihealth's animal-derived protein ingredient portfolio for cosmetics, food and biomedical applications.
• Rousselot (Tessenderlo Group): Rousselot is a global supplier of gelatin and collagen hydrolysates to food, nutrition and pharma markets. Its Peptan and X-Pure brands directly compete with matrihealth's matriVital collagen-elastin blends (matriVital 50) in the functional foods and supplements space.

Broad incumbents

• Symrise AG: Symrise produces flavors, fragrances and cosmetic actives including bioactive peptides for skincare and nutrition. Overlaps with matrihealth's matripure cosmetic-grade elastin and matriVital food-grade hydrolysates through its Diana Foods and cosmetic ingredients divisions.
• Evonik Industries (Health & Beauty Care, Amino Acids): Evonik produces specialty amino acids, peptides and protein hydrolysates for cosmetics, nutrition and healthcare, including bioprocess-grade collagen/elastin research materials. Overlaps with matrihealth's amino-enriched (ELAMIN+) and peptide product families through a much larger portfolio.
• Croda International: Croda is a global specialty ingredients supplier serving personal care, life sciences and industrial markets. Competes broadly with matrihealth in high-purity cosmetic actives (matripure) and offers much larger scale, R&D infrastructure and global distribution.

Emerging players

• CELLINK (BICO Group): CELLINK/BICO is a leading bioconvergence company offering bioinks and 3D bioprinters. While not producing elastin directly, it is an adjacent competitor/partner for matrihealth's ELMA bioprinting-grade elastin in tissue engineering workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/matrihealth

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about matrihealth